Beta-Blockade in Aneurysmal Subarachnoid Hemorrhage: a Systematic Review and Meta-Analysis.

Aravind V RameshCharis F K BanksPeter E MounstephenKate CrewdsonMatt Thomas

Published in: Neurocritical care (2021)

In adult patients with aSAH, beta-blocker therapy is associated with a mortality benefit. Studies are generally of a low quality with considerable clinical heterogeneity. Prospective large interventional trials with patient centered outcomes are required to validate this finding.

Keyphrases

cardiovascular events
single cell
risk factors
case control
stem cells
type diabetes
cardiovascular disease
angiotensin converting enzyme
metabolic syndrome
mesenchymal stem cells
insulin resistance